​Proposed Protocol

​

• Risk of incident diabetes mellitus associated with mRNA, inactivated COVID-19 vaccines and COVID-19 infection: a population-based cohort study
   

• Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac): a case-control study

​

• Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac): a retrospective cohort study
   

• Adverse Events of Special Interest and mortality following the mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines
   

• Two-dose Covid-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong